165 related articles for article (PubMed ID: 16794999)
1. Renin-induced hypertension in Wilms tumor patients.
Maas MH; Cransberg K; van Grotel M; Pieters R; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2007 May; 48(5):500-3. PubMed ID: 16794999
[TBL] [Abstract][Full Text] [Related]
2. Effect of enalaprilat on postoperative hypertension after surgical repair of coarctation of the aorta.
Rouine-Rapp K; Mello DM; Hanley FL; Mohan Reddy V; Soifer S
Pediatr Crit Care Med; 2003 Jul; 4(3):327-32. PubMed ID: 12831415
[TBL] [Abstract][Full Text] [Related]
3. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
Steele JL; Henik RA; Stepien RL
Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747
[TBL] [Abstract][Full Text] [Related]
4. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
5. Interaction between serum cholesterol levels and the renin-angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure.
Borghi C; Veronesi M; Cosentino E; Cicero AF; Kuria F; Dormi A; Ambrosioni E
J Hypertens; 2007 Oct; 25(10):2051-7. PubMed ID: 17885547
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure and renal outcomes in patients with kidney infarction and hypertension.
Paris B; Bobrie G; Rossignol P; Le Coz S; Chedid A; Plouin PF
J Hypertens; 2006 Aug; 24(8):1649-54. PubMed ID: 16877969
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure.
Björck S; Aurell M
J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S59-63. PubMed ID: 16989067
[TBL] [Abstract][Full Text] [Related]
8. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS
Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
[TBL] [Abstract][Full Text] [Related]
9. Critical role for p47phox in renin-angiotensin system activation and blood pressure regulation.
Grote K; Ortmann M; Salguero G; Doerries C; Landmesser U; Luchtefeld M; Brandes RP; Gwinner W; Tschernig T; Brabant EG; Klos A; Schaefer A; Drexler H; Schieffer B
Cardiovasc Res; 2006 Aug; 71(3):596-605. PubMed ID: 16843452
[TBL] [Abstract][Full Text] [Related]
10. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
11. Renal function outcomes in patients treated with nephron sparing surgery for bilateral Wilms tumor.
Giel DW; Williams MA; Jones DP; Davidoff AM; Dome JS
J Urol; 2007 Oct; 178(4 Pt 2):1786-9; discussion 1789-90. PubMed ID: 17707428
[TBL] [Abstract][Full Text] [Related]
12. Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?
Weir MR
Curr Opin Nephrol Hypertens; 2007 Sep; 16(5):416-21. PubMed ID: 17693755
[TBL] [Abstract][Full Text] [Related]
13. Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
Tsutamoto T; Tanaka T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
Hypertens Res; 2009 Aug; 32(8):670-4. PubMed ID: 19498438
[TBL] [Abstract][Full Text] [Related]
14. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
Hood SJ; Taylor KP; Ashby MJ; Brown MJ
Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
[TBL] [Abstract][Full Text] [Related]
15. Vasoconstrictor-induced hypertension following multiple blood transfusions in children with congenital hemolytic anemia.
Assadi F
Iran J Kidney Dis; 2008 Jul; 2(3):132-6. PubMed ID: 19377226
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
17. Hypertension in childhood cancer: a frequent complication of certain tumor sites.
Madre C; Orbach D; Baudouin V; Brisse H; Bessa F; Schleiermacher G; Pacquement H; Doz F; Michon J
J Pediatr Hematol Oncol; 2006 Oct; 28(10):659-64. PubMed ID: 17023826
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Wilms tumor-related hypertension with losartan and captopril.
Wong W; Mauger D
Pediatr Nephrol; 2004 Jul; 19(7):805-7. PubMed ID: 15133726
[TBL] [Abstract][Full Text] [Related]
19. Reninoma: case report and literature review.
Wong L; Hsu TH; Perlroth MG; Hofmann LV; Haynes CM; Katznelson L
J Hypertens; 2008 Feb; 26(2):368-73. PubMed ID: 18192852
[TBL] [Abstract][Full Text] [Related]
20. [Is there a need for direct renin inhibitors?].
Grossman E
Harefuah; 2008 Mar; 147(3):216-7, 278. PubMed ID: 18488862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
